Vaxcyte, Inc. (PCVX)

Vaxcyte (PCVX) Financial Statements


Vaxcyte Financial Overview

Vaxcyte's market cap is currently ―. The company's EPS TTM is $-4.355; its P/E ratio is -16.71; Vaxcyte is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.98. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -114.35M$ -180.80M$ -92.66M$ -68.34M$ -70.86M
EBITDA$ -111.25M$ -177.85M$ -104.76M$ -77.78M$ -71.56M
Net Income Common Stockholders$ -95.02M$ -180.80M$ -92.66M$ -68.34M$ -60.46M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.49B$ 1.08B$ 1.27B$ 1.29B$ 822.04M
Total Assets$ 2.09B$ 1.41B$ 1.50B$ 1.50B$ 1.01B
Total Debt$ 27.42M$ 29.22M$ 13.81M$ 15.21M$ 16.59M
Net Debt$ -1.46B$ -1.05B$ -1.25B$ -1.27B$ -805.45M
Total Liabilities$ 107.32M$ 167.45M$ 93.34M$ 69.44M$ 63.39M
Stockholders Equity$ 1.98B$ 1.24B$ 1.40B$ 1.43B$ 944.77M
Cash Flow-
Free Cash Flow$ -164.80M$ -185.88M$ -64.89M$ -60.60M$ -53.30M
Operating Cash Flow$ -159.12M$ -128.81M$ -57.55M$ -62.74M$ -47.69M
Investing Cash Flow$ -451.07M$ -13.93M$ 22.28M$ -333.56M$ -448.10M
Financing Cash Flow$ 818.20M$ 2.73M$ 48.55M$ 546.97M$ 41.56M
Currency in USD

Vaxcyte Earnings and Revenue History

Vaxcyte Debt to Assets

Vaxcyte Cash Flow

Vaxcyte Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis